M Grabowsky, L Markowitz. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisHumansImmunization/economicsMass Screening/economicsMeasles/prevention & control
Year: 1991 PMID: 1955727 DOI: 10.1093/infdis/164.6.1237
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226